Navigation Links
Arno Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
Date:11/3/2008

ments:

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, outlook, milestones, the success of Arno's product development, future financial position, future financial results, plans and objectives of management are forward-looking statements. We may not actually achieve these plans, intentions or expectations and Arno cautions investors not to place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. Various important factors that could cause actual results or events to differ materially from the forward-looking statements that we make are described in greater detail in the reports we file with Securities and Exchange Commission, including those described under the caption "Risk Factors" in our Current Report on Form 8-K filed with the Securities and Exchange Commission on June 9, 2008. Arno is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements as a result of new information, future events or otherwise.


'/>"/>
SOURCE Arno Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Halozyme Therapeutics Begins Phase 2 Clinical Trial of Insulin With rHuPH20 in Type 1 Diabetic Patients
2. Halozyme Therapeutics Announces Conference Call on November 6 to Review Third Quarter Results
3. United Therapeutics Reports Third Quarter 2008 Financial Results
4. Arete Therapeutics Bolsters Management Team
5. Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics
6. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
7. Nile Therapeutics to Present at the 7th Annual BIO Investor Forum
8. Nektar Therapeutics to Webcast R&D Day on November 12th
9. Amicus Therapeutics Announces Third Quarter 2008 Results Release Date
10. Sir Richard Sykes Joins BioCeramic Therapeutics as Chairman
11. Leading Heart Specialist Joins Duska Therapeutics as Scientific Consultant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , August 3, 2015 ... Portland Hospital waved the shortfall of ... could stand normally for the first time. ... (Photo: http://photos.prnewswire.com/prnh/20150803/254229 ) The Selective ... legs allowing him to carry out his wish to ...
(Date:8/3/2015)... LOUIS (PRWEB) , ... August 03, 2015 , ... Nine ... in Iowa, Illinois and Indiana. Hosted by the Soil Health Partnership , the ... create lasting environmental benefits while potentially increasing farm productivity and income. , Brent Bible ...
(Date:8/3/2015)... 2015 According to a new ... Culture: Asia to Witness Highest ... global 3D cell culture market was valued at US$ 586.1 Mn ... CAGR of 29.1% to account for US$ 2,717.6 Mn ... http://www.persistencemarketresearch.com/market-research/3d-cell-cultures-market.asp 3D cell culture refers to ...
(Date:7/31/2015)... ... July 31, 2015 , ... Global Resorcinol ... premium industry insights on the global resorcinol industry. The report highlights the various ... vivid market scenarios and analysis of primary and secondary inputs from the existing ...
Breaking Biology Technology:Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 2Cerebral Palsy Operation by The Portland Hospital Allows a Boy to Stand Properly for the First Time 3Soil Health Field Days Kick Off Throughout Midwest 2Soil Health Field Days Kick Off Throughout Midwest 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 2Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 4Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 2Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 3Resorcinol Market to Grow at 6% CAGR to 2019 Says New Research Report at ReportsnReports.com 4
... announced that data from Phase 2 studies for its ... (SB939) demonstrate promising activity in patients with myelofibrosis (MF). ... Meeting and Exposition in San Diego, Calif. ... activity in alleviating MF-associated splenomegaly and constitutional symptoms with ...
... field of vision is a step closer to reality with ... provide the wearer with hands-free information updates. In ... Journal of Micromechanics and Microengineering , researchers constructed a computerised ... live eyes. There were no signs of adverse side effects. ...
... Office of Scientific Research (AFOSR) was chosen by Time Magazine for ... Ali Aliev, Yuri Gartstein and Ray Baughman, of the University of ... referred to as the "mirage effect from thermally modulated transparent carbon ... it: an ,invisibility cloak,." The key ...
Cached Biology Technology:S*BIO's Novel JAK2 Inhibitor Pacritinib (SB1518) and Histone Deacetylase Inhibitor Pracinostat (SB939) Demonstrate Promising Activity in Phase 2 Studies for Patients with Myelofibrosis (MF) 2S*BIO's Novel JAK2 Inhibitor Pacritinib (SB1518) and Histone Deacetylase Inhibitor Pracinostat (SB939) Demonstrate Promising Activity in Phase 2 Studies for Patients with Myelofibrosis (MF) 3Terminator-style info-vision takes step towards reality 2
(Date:7/27/2015)... , July 27, 2015   Zynx Health ... experience-based clinical improvement solutions, today announced that its ... now available on Android smartphones and tablets. With ... post-care organizations can use ZynxCarebook to securely exchange ... condition, streamline care transitions to other care settings, ...
(Date:7/21/2015)... , July 21, 2015 Passwords have ... seen in the recent U.S. Office of Personnel ... to the infosec conundrum, but developers and end-users ... To address this dilemma, Biometrics-as-a-Service provider HYPR Corp. ... Tokenization SDK for third party integration. ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
Breaking Biology News(10 mins):Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... evangelical movement is defined has profound implications for where ... study by sociologists at Rice University and the University ... much debate over whether Sen. Obama can shave off ... Rice,s D. Michael Lindsay, one of the researchers. "That ...
... , Plants that grow more slowly stay ... Biology, scientists at the Max Planck Institute for Developmental ... of genes, so-called microRNAs, coordinate growth and aging processes ... TCP transcription factors. These transcription factors in turn influence ...
... for Applied Physics will be awarded to Phaedon Avouris ... electrical and optical properties of nanoscale carbon materials including ... The award, accompanied by US$ 5,000, will be presented ... at Harvard University in Cambridge, MA, on 27 September ...
Cached Biology News:New study looks to define evangelicals and how they affect polling 2Formula discovered for longer plant life 2Carbon nanostructures form the future of electronics and optoelectronics 2
... length insert sequencing service for large insert ... Agencourt utilizes unique library construction techniques ... are several features that allow Agencourt to ... turnaround including our patented magnetic bead-based SPRI ...
... maintenance, calibration, and validation (MCV) ... plate used for hands-free startup, ... using the Bio-Plex suspension array ... for use with Bio-Plex Manager ...
A flexible 24-48 hour DNA sequencing service. Samples may be shipped in standard 1.5mL tubes. Oligo synthesis and DNA preparation available. Read lengths up to 850 Phred 20 bases. Universal primers p...
... Agencourts cDNA sequencing and finishing services ... Agencourt can perform large-scale 5' screening ... finishing. Our considerable experience with large-scale ... make Agencourt an ideal cDNA outsourcing ...
Biology Products: